Pink Sheet: 世界の薬事規制と承認審査に関するニュース

Webinar: FDA and its Commissioners

By nielsen-hobbs 05 Nov 2019

The US FDA has experienced an extended period with an acting commissioner. However, the agency continues to achieve its user fee dates, and hardly appears rudderless. Still, having a confirmed commissioner will give FDA more stability and power. But with application review looking to become more efficient and flexible, what could a new commissioner do to change the relationship between industry and FDA?

Topic fda

Topic medtech digital-health

Topic biopharmaceutical clinical-trials

Topic cell-and-gene-therapy

Topic immuno-oncology Infectious diseases

Topic drug-approval drug-development-landscape drug-review

Topic business-strategies

Topic Biosimilars